vs
STANDARD BIOTOOLS INC.（LAB）与淘屏（TAOP）财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是淘屏的1.1倍（$19.6M vs $17.6M），淘屏净利率更高（-26.6% vs -177.4%，领先150.8%），淘屏同比增速更快（-2.6% vs -11.5%），淘屏自由现金流更多（$-2.8M vs $-23.1M）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
淘屏有限公司是总部位于中国的科技企业，主营智能云服务、数字媒体解决方案及精准互联网广告业务，核心业务覆盖智慧城市建设支持、企业数字化转型工具及线下新零售数字运营服务，服务国内企业与公共部门客户。
LAB vs TAOP — 直观对比
营收规模更大
LAB
是对方的1.1倍
$17.6M
营收增速更快
TAOP
高出8.8%
-11.5%
净利率更高
TAOP
高出150.8%
-177.4%
自由现金流更多
TAOP
多$20.3M
$-23.1M
损益表 — Q3 FY2025 vs Q2 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $17.6M |
| 净利润 | $-34.7M | $-4.7M |
| 毛利率 | 48.5% | 10.1% |
| 营业利润率 | -168.5% | -23.8% |
| 净利率 | -177.4% | -26.6% |
| 营收同比 | -11.5% | -2.6% |
| 净利润同比 | -28.8% | -894.8% |
| 每股收益（稀释后） | $-0.09 | $-6.54 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LABTAOP
| Q3 25 | $19.6M | — | ||
| Q2 25 | $21.8M | $17.6M | ||
| Q1 25 | $40.8M | — | ||
| Q4 24 | — | $18.6M | ||
| Q3 24 | $22.1M | — | ||
| Q2 24 | $22.5M | $18.1M | ||
| Q1 24 | $45.5M | — | ||
| Q4 23 | $28.2M | — |
净利润LABTAOP
| Q3 25 | $-34.7M | — | ||
| Q2 25 | $-33.5M | $-4.7M | ||
| Q1 25 | $-26.0M | — | ||
| Q4 24 | — | $-2.4M | ||
| Q3 24 | $-26.9M | — | ||
| Q2 24 | $-45.7M | $588.7K | ||
| Q1 24 | $-32.2M | — | ||
| Q4 23 | $-19.8M | — |
毛利率LABTAOP
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | 10.1% | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | 19.5% | ||
| Q3 24 | 54.9% | — | ||
| Q2 24 | 46.1% | 22.9% | ||
| Q1 24 | 53.1% | — | ||
| Q4 23 | 47.6% | — |
营业利润率LABTAOP
| Q3 25 | -168.5% | — | ||
| Q2 25 | -118.1% | -23.8% | ||
| Q1 25 | -80.8% | — | ||
| Q4 24 | — | -8.0% | ||
| Q3 24 | -120.9% | — | ||
| Q2 24 | -134.5% | -0.7% | ||
| Q1 24 | -132.2% | — | ||
| Q4 23 | -75.9% | — |
净利率LABTAOP
| Q3 25 | -177.4% | — | ||
| Q2 25 | -153.7% | -26.6% | ||
| Q1 25 | -63.8% | — | ||
| Q4 24 | — | -13.0% | ||
| Q3 24 | -122.0% | — | ||
| Q2 24 | -203.3% | 3.3% | ||
| Q1 24 | -70.6% | — | ||
| Q4 23 | -70.2% | — |
每股收益（稀释后）LABTAOP
| Q3 25 | $-0.09 | — | ||
| Q2 25 | $-0.09 | $-6.54 | ||
| Q1 25 | $-0.07 | — | ||
| Q4 24 | — | $-3.58 | ||
| Q3 24 | $-0.07 | — | ||
| Q2 24 | $-0.12 | $3.29 | ||
| Q1 24 | $-0.27 | — | ||
| Q4 23 | $-0.24 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $2.2M |
| 总债务越低越好 | — | $5.8M |
| 股东权益账面价值 | $399.7M | $14.5M |
| 总资产 | $539.6M | $30.3M |
| 负债/权益比越低杠杆越低 | — | 0.40× |
8季度趋势，按日历期对齐
现金及短期投资LABTAOP
| Q3 25 | $129.4M | — | ||
| Q2 25 | $158.6M | $2.2M | ||
| Q1 25 | $150.9M | — | ||
| Q4 24 | — | $1.6M | ||
| Q3 24 | $210.6M | — | ||
| Q2 24 | $269.8M | $480.3K | ||
| Q1 24 | $287.1M | — | ||
| Q4 23 | $51.7M | — |
总债务LABTAOP
| Q3 25 | — | — | ||
| Q2 25 | — | $5.8M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $5.8M | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — | ||
| Q1 24 | $55.0M | — | ||
| Q4 23 | $63.5M | — |
股东权益LABTAOP
| Q3 25 | $399.7M | — | ||
| Q2 25 | $424.5M | $14.5M | ||
| Q1 25 | $454.6M | — | ||
| Q4 24 | — | $15.9M | ||
| Q3 24 | $489.3M | — | ||
| Q2 24 | $510.3M | $15.8M | ||
| Q1 24 | $577.3M | — | ||
| Q4 23 | $-148.1M | — |
总资产LABTAOP
| Q3 25 | $539.6M | — | ||
| Q2 25 | $557.0M | $30.3M | ||
| Q1 25 | $579.6M | — | ||
| Q4 24 | — | $35.1M | ||
| Q3 24 | $681.5M | — | ||
| Q2 24 | $708.7M | $34.1M | ||
| Q1 24 | $777.7M | — | ||
| Q4 23 | $323.1M | — |
负债/权益比LABTAOP
| Q3 25 | — | — | ||
| Q2 25 | — | 0.40× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.37× | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.10× | — | ||
| Q4 23 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $-1.5M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $-2.8M |
| 自由现金流率自由现金流/营收 | -118.1% | -16.0% |
| 资本支出强度资本支出/营收 | 4.5% | 7.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-111.1M | — |
8季度趋势，按日历期对齐
经营现金流LABTAOP
| Q3 25 | $-22.2M | — | ||
| Q2 25 | $-20.7M | $-1.5M | ||
| Q1 25 | $-30.3M | — | ||
| Q4 24 | — | $147.4K | ||
| Q3 24 | $-27.9M | — | ||
| Q2 24 | $-39.0M | $-2.5M | ||
| Q1 24 | $-62.5M | — | ||
| Q4 23 | $-14.1M | — |
自由现金流LABTAOP
| Q3 25 | $-23.1M | — | ||
| Q2 25 | $-22.6M | $-2.8M | ||
| Q1 25 | $-35.3M | — | ||
| Q4 24 | — | $-129.3K | ||
| Q3 24 | $-30.1M | — | ||
| Q2 24 | $-41.0M | $-3.3M | ||
| Q1 24 | $-63.3M | — | ||
| Q4 23 | $-14.1M | — |
自由现金流率LABTAOP
| Q3 25 | -118.1% | — | ||
| Q2 25 | -103.6% | -16.0% | ||
| Q1 25 | -86.6% | — | ||
| Q4 24 | — | -0.7% | ||
| Q3 24 | -136.4% | — | ||
| Q2 24 | -182.2% | -18.3% | ||
| Q1 24 | -138.9% | — | ||
| Q4 23 | -50.2% | — |
资本支出强度LABTAOP
| Q3 25 | 4.5% | — | ||
| Q2 25 | 8.7% | 7.6% | ||
| Q1 25 | 12.4% | — | ||
| Q4 24 | — | 1.5% | ||
| Q3 24 | 10.2% | — | ||
| Q2 24 | 8.6% | 4.3% | ||
| Q1 24 | 1.7% | — | ||
| Q4 23 | 0.3% | — |
现金转化率LABTAOP
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -4.30× | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
TAOP
暂无分部数据
